Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis.
JAAD Case Rep
; 31: 1-5, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36458235
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
JAAD Case Rep
Year:
2023
Document type:
Article
Affiliation country:
Italy